| Rosalie Turek, MD | |
|
818 Riverside Ave, Adrian, MI 49221-1446 | |
| (517) 265-0900 | |
| Not Available |
| Full Name | Rosalie Turek |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine - Emergency Medical Services |
| Location | 818 Riverside Ave, Adrian, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821023185 | NPI | - | NPPES |
| 104867852 | Medicaid | MI | |
| 104515715 | Medicaid | MI | |
| 104515751 | Medicaid | MI | |
| RT047435 | Other | MI | BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 047435 (Michigan) | Primary |
| 207P00000X | Emergency Medicine | 4301047435 (Michigan) | Secondary |
| Entity Name | Michigan Urgent Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982060935 PECOS PAC ID: 8820396419 Enrollment ID: O20160414001942 |
News Archive
The University of Chicago Medicine will begin treating adult and pediatric patients at its new orthopaedic center in Orland Park on April 6.
BTG plc, the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California.
Today, Formatech, Inc. announced that it has selected Femta's FM101 therapeutic candidate to be enrolled in its Fillanthropy Program. Under this program, Formatech will donate the services required to aseptically fill and finish one lot of the drug candidate for use in support of Femta's upcoming clinical trials.
Leading researcher Dr. Andrew Wilson from the University of East Anglia has been awarded £1.7million in funding from the National Institute for Health Research, enabling the Asthma UK Centre for Applied Research to identify people most at risk of an asthma attack in order to reduce the high number of avoidable asthma deaths.
› Verified 5 days ago
| Entity Name | Nextcare Michigan Providers Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972106938 PECOS PAC ID: 5395157218 Enrollment ID: O20201218000348 |
News Archive
The University of Chicago Medicine will begin treating adult and pediatric patients at its new orthopaedic center in Orland Park on April 6.
BTG plc, the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California.
Today, Formatech, Inc. announced that it has selected Femta's FM101 therapeutic candidate to be enrolled in its Fillanthropy Program. Under this program, Formatech will donate the services required to aseptically fill and finish one lot of the drug candidate for use in support of Femta's upcoming clinical trials.
Leading researcher Dr. Andrew Wilson from the University of East Anglia has been awarded £1.7million in funding from the National Institute for Health Research, enabling the Asthma UK Centre for Applied Research to identify people most at risk of an asthma attack in order to reduce the high number of avoidable asthma deaths.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rosalie Turek, MD 2000 Green Rd, Suite 300, Ann Arbor, MI 48105-1598 Ph: () - | Rosalie Turek, MD 818 Riverside Ave, Adrian, MI 49221-1446 Ph: (517) 265-0900 |
News Archive
The University of Chicago Medicine will begin treating adult and pediatric patients at its new orthopaedic center in Orland Park on April 6.
BTG plc, the global healthcare company, highlighted the presentation of OPTALYSE PE trial results at the Society for Cardiovascular Angiography and Interventions in San Diego, California.
Today, Formatech, Inc. announced that it has selected Femta's FM101 therapeutic candidate to be enrolled in its Fillanthropy Program. Under this program, Formatech will donate the services required to aseptically fill and finish one lot of the drug candidate for use in support of Femta's upcoming clinical trials.
Leading researcher Dr. Andrew Wilson from the University of East Anglia has been awarded £1.7million in funding from the National Institute for Health Research, enabling the Asthma UK Centre for Applied Research to identify people most at risk of an asthma attack in order to reduce the high number of avoidable asthma deaths.
› Verified 5 days ago
Howard Merritt, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 818 Riverside Ave, Adrian, MI 49221 Phone: 517-265-0900 | |
Vanessa Vivian Calabria, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 818 Riverside Ave, Adrian, MI 49221 Phone: 517-265-0900 |